表紙:医薬品・バイオ医薬品・機能性食品向け分析装置の世界市場:将来予測 (2025年まで)
市場調査レポート
商品コード
914940

医薬品・バイオ医薬品・機能性食品向け分析装置の世界市場:将来予測 (2025年まで)

Global Analytical Instrumentation Market in Pharmaceuticals, Biopharmaceuticals, and Nutraceuticals, Forecast to 2025

出版日: | 発行: Frost & Sullivan | ページ情報: 英文 98 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=135.61円
医薬品・バイオ医薬品・機能性食品向け分析装置の世界市場:将来予測 (2025年まで)
出版日: 2019年10月17日
発行: Frost & Sullivan
ページ情報: 英文 98 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

世界の医薬品・バイオ医薬品・機能性食品向け分析装置の市場規模は、2018年の30億5670万米ドルから、2025年には49億1140万米ドルにまで拡大する見通しです。ただし、メーカー側には強い価格引き下げ圧力がかかるため、柔軟な価格戦略を構築して顧客に対応する必要があります。地域別ではアジア太平洋地域の成長が著しく、特に中国が研究開発 (R&D) の中核として台頭しつつあります。

当レポートでは、世界の医薬品・バイオ医薬品・機能性食品向け分析装置の市場について分析し、基本的な市場構造や主な促進・抑制要因、全体的な市場規模の動向見通し (今後8年間分)、分野別・地域別の詳細動向、業界関係者が今後取るべき戦略、といった情報を取りまとめてお届けいたします。

エグゼクティブサマリー

市場概要

市場促進・抑制要因:医薬品・バイオ医薬品・機能性食品向け分析装置の市場

  • 市場促進要因
  • 市場抑制要因

全体的な予測と傾向:医薬品・バイオ医薬品・機能性食品向け分析装置の市場

  • 市場エンジニアリング計測
  • 市場予測の前提条件
  • 市場収益額の予測
  • 価格動向の分析
  • 市場収益額シェアの予測:地域別
  • 市場収益額の予測:地域別
  • 地域市場の主な動向:北米
  • 地域市場の主な動向:欧州
  • 地域市場の主な動向:アジア太平洋地域
  • 地域市場の主な動向:他の国々 (RoW)
  • 市場収益額の予測:産業別
  • 最大手企業
  • 製品の概略

成長機会と企業が取るべき行動

  • 成長機会 (1):機能性食品
  • 成長機会 (2):バイオシミラー
  • 成功・成長のための戦略的課題

医薬品市場の分析

  • 分析概略
  • 市場エンジニアリング計測
  • 市場収益額の予測
  • 市場収益額の予測:製品別
  • 市場シェア分析
  • 競争環境

バイオ医薬品市場の分析

機能性食品 (栄養補助食品) 市場の分析

インド市場の詳細動向

  • 分析概略
  • 市場収益額の予測
  • 市場収益額の予測:産業別
  • 市場区分:医薬品
  • 市場区分:バイオ医薬品
  • 市場区分:機能性食品
  • 市場シェア分析
  • 競争環境

結論

  • 3通りの主な予測

付録

目次
Product Code: K3BA-30

Global Analytical Instrumentation Market in Pharmaceuticals, Biopharmaceuticals, and Nutraceuticals, Forecast to 2025

The global pharmaceuticals, biopharmaceuticals, and neutraceuticals market includes market revenues of analytical instrumentation applied in the 3 segments. Analytical instruments are applied in research, development, manufacturing, quality control, and distribution of drugs. Some key applications include (and are not limited to) drug discovery and development testing, biopharmaceutical analytical testing, quality control testing, cancer research, and process technology analysis.

Neutraceutical includes analytical equipment used for functional food and beverages, dietary supplements, and herbals. Geographic scope is global. Different techniques, including chromatographs, mass spectrometers, infrared spectrometers, UV-Vis spectrometers, Raman spectrometers, thermal analyzers, and X-ray diffractometers are included under different applications. The total analytical instrumentation market in pharmaceuticals, biopharmaceuticals, and neutraceuticals was estimated at $3056.7 million in 2018, and is expected to reach $4911.4 million in 2025. There is a high pricing pressure on drug manufacturers to cut down costs. Hence, manufacturers would have to create a flexible pricing strategy to maximize their profits and negotiate with payers. Process analyzers that can be plugged in as part of the manufacturing process would reduce operating costs for manufacturers.

The pharmaceutical market in 2018 oversaw massive vertical integration of organizations. This would lead to cost efficiency and innovation in the industry.

Asia-Pacific is a large focus for pharmaceutical manufacturers, especially China. China has become a hub for innovation and R&D.

With the increasing approval for biosimilars in the United States, there would be significant cost cuts in the country, motivated by government institutions such as the National Health Service (NHS). The price differential between biosimilars and their branded counterparts is 30%. US political uncertainity and Brexit would negatively impact pharmaceutical market growth.

Manufacturers are offering exclusive biopharmaceutical solutions to resolve challenges associated with biological drugs. The intention of avoiding side effects-imposing small molecules and complex surgical procedures has led to targeted therapies of biologics. By 2020, analysts will expect biological drugs to capture about a quarter of the total small molecules market.

Growth of biological drugs is expected to continue, as biological blockbuster drugs keep entering the market. The penetration of biologic drugs will increase from 25% in 2016 to 30% in 2022.

Neutraceuticals are gaining importance and becoming a part of consumers' daily diet. Lifestyle, health disorders, and lack of exercise are leading to the segment's growth. Ingredients and raw material contamination, less awareness, and unclear regulations are challenging market growth.

Neutraceuticals are often dietary supplements or food additives. They offer benefits such as preventing and curing diseases. Functional beverages such as energy drinks that contain stimulants to make the brain active are also popular.

Table of Contents

Executive Summary

  • Key Findings
  • Market Engineering Measurements
  • Market Engineering Measurements (continued)
  • CEO's Perspective

Market Overview

  • Market Scope and Definitions
  • Key Questions this Study will Answer
  • Market Segmentation

Drivers and Restraints-Total Analytical Instrumentation Market in Pharmaceuticals, Biopharmaceuticals, and Neutraceuticals

  • Market Drivers
  • Drivers Explained
  • Drivers Explained (continued)
  • Drivers Explained (continued)
  • Market Restraints
  • Restraints Explained

Forecasts and Trends-Total Analytical Instrumentation Market in Pharmaceuticals, Biopharmaceuticals, and Neutraceuticals

  • Market Engineering Measurements
  • Market Engineering Measurements (continued)
  • Forecast Assumptions
  • Revenue Forecast
  • Revenue Forecast Discussion
  • Pricing Analysis
  • Percent Revenue Forecast by Region
  • Revenue Forecast by Region
  • Top Trends in North America
  • Top Trends in Europe
  • Top Trends in Asia-Pacific
  • Top Trends in ROW
  • Revenue Forecast by Vertical Market
  • Top Competitors
  • Product Highlights

Growth Opportunities and Companies to Action

  • Growth Opportunity 1-Neutraceuticals
  • Growth Opportunity 2-Biosimilars
  • Strategic Imperatives for Success and Growth

Pharmaceutical Segment Analysis

  • Key Findings
  • Market Engineering Measurements
  • Revenue Forecast
  • Revenue Forecast Discussion
  • Revenue Forecast by Product
  • Revenue Forecast Discussion by Product
  • Market Share
  • Market Share Analysis
  • Market Share Analysis (continued)
  • Competitive Environment

Biopharmaceutical Segment Analysis

  • Key Findings
  • Market Engineering Measurements
  • Revenue Forecast
  • Revenue Forecast Discussion
  • Revenue Forecast by Product
  • Revenue Forecast Discussion by Product
  • Market Share
  • Market Share Analysis
  • Market Share Analysis (continued)
  • Competitive Environment

Neutraceuticals Segment Analysis

  • Key Findings
  • Market Engineering Measurements
  • Revenue Forecast
  • Revenue Forecast Discussion
  • Revenue Forecast by Product
  • Revenue Forecast Discussion by Product
  • Market Share
  • Market Share Analysis
  • Competitive Environment

India Breakdown

  • Key Findings
  • Revenue Forecast
  • Revenue Forecast Discussion
  • Revenue Forecast by Vertical Market
  • Revenue Forecast Discussion by Vertical Market
  • Market Segmentation-Pharmaceuticals
  • Market Segmentation-Biopharmaceuticals
  • Market Segmentation-Neutraceuticals
  • Market Share
  • Market Share Analysis
  • Competitive Environment

The Last Word

  • The Last Word-3 Big Predictions
  • Legal Disclaimer

Appendix

  • Market Engineering Methodology
  • Additional Sources of Information on Study Topic
  • List of Companies in "Others"
  • Partial List of Companies Interviewed
  • List of Exhibits
  • List of Exhibits (continued)
  • List of Exhibits (continued)